Indicators for Monitoring National Drug Policies
(1999; 250 pages) [French] View the PDF document
Table of Contents
View the documentACKNOWLEDGEMENTS
Open this folder and view contentsCHAPTER I: Introduction
Open this folder and view contentsCHAPTER II: Development of the manual
Open this folder and view contentsCHAPTER III: Model lists of indicators
Open this folder and view contentsCHAPTER IV: Methodology for indicator calculation
Open this folder and view contentsCHAPTER V: Detailed presentation of indicators
Close this folderANNEX 1: Data collection forms
View the documentData Collection Form 1 - Private drug outlets
View the documentData Collection Form 2 - Public sector drug outlets
View the documentData Collection Form 3 - Health facilities/prescribers
View the documentData Collection Form 4 - Remote health facilities
View the documentSummary Form 1 - National drug policy background information
View the documentSummary Form 2 - National drug policy structural indicators
View the documentSummary Form 3 - National drug policy process indicators
View the documentSummary Form 4 - National drug policy outcome indicators
View the documentANNEX 2: Glossary
View the documentANNEX 3: Table of random numbers
View the documentBACK COVER
 

Data Collection Form 3 - Health facilities/prescribers

Data Collection Form 3 allows collection of all the data needed from public and private health facilities to calculate process indicators PR33 and 35 and outcome indicator OT9 (see page 46). A form should be filled in in each health facility visited.

Name of drug outlet:

..............................................................................

Location:

..............................................................................

Data collectors:

..............................................................................


..............................................................................

Date of data collection:

..............................................................................

1. Collecting data for process indicator PR33:

• The monitoring unit should provide data collectors with the list of manuals, formularies, etc. which can be taken into account for the calculation of this indicator.

• Ask selected prescribers the following question:

"Could you show us a copy of the national or regional formulary, or any manual containing objective and independent information on drugs?"

• Observe if the formulary is immediately visible on the prescriber's desk (1), elsewhere in the office (2) or not available (3). Fill in the box with 1, 2 or 3.

• Please write the title and author of the document:
_______________________________________________________________
_______________________________________________________________

2. Collecting data for process indicator PR35:

• Ask selected prescribers the following question:

"Have you attended at least one training session where problems related to the rational use of drugs were discussed in the past year?"

1 = yes, 2 = no


Please write the title of training session:

____________________________________


Dates:

____________________________________


Place:

____________________________________


Organized by:

____________________________________

A training session is defined as any meeting, workshop, seminar, etc. in which problems related to the rational use of drugs are discussed. Only training sessions organized by the public sector (i.e. ministry of health) and/or non-profit institutions and/or professional organizations (i.e. medical associations) should be considered. Any meeting organized/supported by the pharmaceutical industry cannot be considered as a training session.

3. Collecting data for outcome indicator OT9:

• Copy the first 5 prescriptions seen for children under 5 years old with diarrhoea, in column 1.

• Column 2 can be filled in during the survey or after by the monitoring unit.

Prescription number

1
Drug prescribed
(name, form and strength)

2
Antidiarrhoeal drug
(Yes/No)

1.















2.















3.















4.















5.















TOTAL


to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: June 25, 2014